Arcturus Therapeutics Holdings (ARCT) Key Ratios

Stock Card

$15.82

$0.26 (1.67%)

As on 04-Sep-2026 16:00EDT

Market cap

$450 Mln

Revenue (TTM)

$24 Mln

P/E Ratio

P/B Ratio

2.6

Div. Yield

0 %

Key Ratios and Highlights

Growth Score (%)	Quarterly		Annual (TTM)
Particulars	QoQ	YoY	1-Year	3-Years	5-Years
Revenue	385.08	-87.93	-79.07	-55.19	22.30
EBIT	--	--	-1.41	-189.80	10.20
Net Profit	11.79	-159.10	-55.04	-205.13	7.38
EPS	11.80	-147.30	-50.27	-204.94	8.03
Book Value	--	--	-12.45	-7.84	-12.36

Key Ratios (%)	Average		Annual (TTM)
Particulars	3-Years	5-Years	TTM	Dec-25	Dec-24
EBIT-Margin	-57.85	-358.65	-257.27	-97.86	-58.49
Net Margin	--	-1,765.40	-391.90	--	--
Return on equity	-23.64	-26.47	-48.36	-28.92	-31.16
Return on Capital	-20.90	-23.37	--	-25.87	-27.99
Return on Assets	-16.36	-18.74	-30.40	-21.39	-20.93
Debt to Equity (x)	--	--	0.00	0.12	0.12

Profitability

View Detailed Peer Comparison

ROCE

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	--	-25.87	-27.99	-8.82	2.82	-57.00
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROE

-48.36

Lower than Peers by 8.02

Profit after tax / Average Net worth * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	-48.36	-28.92	-31.16	-10.83	3.75	-65.20
Peer Median	-40.33	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROA

-30.40

Higher than Peers by 0.84

Profit after tax / Average Total assets * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	-30.40	-21.39	-20.93	-6.76	2.22	-46.86
Peer Median	-31.24	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EBIT Margin

-257.27

Lower than Peers by 174.67

Operating profit (EBIT) / Net Sales * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	-257.27	-97.86	-58.49	-17.19	6.63	-1,626.35
Peer Median	-82.60	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Margin

-391.90

Lower than Peers by 300.60

Net profit / Total Income (Net sales plus other income) * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	-391.90	-97.86	-58.49	-18.84	4.54	-1,765.40
Peer Median	-91.30	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Cash Profit Margin

0.00

Lower than Peers by 0.00

(Net profit + Depreciation) / Gross Sales * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	0.00	--	--	--	--	--
Peer Median	0.00	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-79.07

Lower than Peers by 133.10

Year on year growth in net sales

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	-79.07	-0.51	-0.12	-0.23	15.65	0.30
Peer Median	54.03	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EBIT Growth

-1.41

Lower than Peers by 0.39

Year on year growth in operating profit (EBIT)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	-1.41	18.73	-198.45	-298.77	106.79	-181.02
Peer Median	-1.02	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Profit Growth

-55.04

Lower than Peers by 47.50

Year on year growth in profit after tax

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	-55.04	18.73	-172.30	-417.95	104.59	-182.30
Peer Median	-7.53	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EPS Growth

-50.27

Lower than Peers by 64.50

Year on year growth in earnings per share

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	-50.27	0.20	-1.69	-4.23	1.04	-1.81
Peer Median	14.23	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Book Value Growth

-29.03

Lower than Peers by 18.89

Year on year growth in book value per share

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	-29.03	--	--	--	--	--
Peer Median	-10.13	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

Total debt / Net worth

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	--	0.12	0.12	0.11	0.35	0.30
Peer Median	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Short term debt to equity ratio

0.02

(Short term borrowings / Net worth)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	0.02	0.02	0.01	0.02	0.24	0.11
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Current Ratio

5.88

Higher than Peers by 0.07

Current Assets / Current Liabilities and Provisions

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	5.88	6.64	4.67	4.72	3.18	3.81
Peer Median	5.81	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Quick Ratio

5.88

Higher than Peers by 0.18

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	5.88	--	--	4.81	--	3.81
Peer Median	5.70	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Interest Coverage

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	--	-7,309.22	--	-35.36	4.55	-75.17
Peer Median	-2.09	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

7.62

Lower than Peers by 11.40

Debtors outstanding / Net Sales * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	7.62	8.28	2.87	20.33	1.34	27.24
Peer Median	19.01	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Asset Turnover

0.08

Higher than Peers by 0.01

Sales / Average Total Assets

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	0.08	0.22	0.36	0.36	0.49	0.03
Peer Median	0.06	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Receivable days

Average Debtors / Sales * 365

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	--	25.91	47.56	40.32	5.44	81.15
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Inventory Days

Average Inventory / Sales * 365

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	--	--	-775.13	-929.00	0.00	0.00
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Payable days

Average Creditors / Cost of goods sold * 365

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	--	689.99	642.74	786.08	22.35	21.89
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Cash Conversion Cycle

Receivable Days + Inventory Days - Payable Days

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	--	--	-1,370.31	-1,674.76	-16.91	59.26
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

Current share price divided by earning per share in the last twelve months

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	--	-2.55	-5.66	-28.24	49.13	-4.79
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Price / Book Value

2.57

Lower than Peers by 2.75

Current share price divided by book value per share in the latest financial year

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	2.57	0.78	1.90	3.01	1.70	4.27
Peer Median	5.33	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Dividend Yield

Dividend per share in the past twelve months divided by current share price

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	--	--	--	--	--	--
Peer Median	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EV/EBITDA

-25.67

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	-25.67	0.61	-3.23	-23.91	10.69	-3.37
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Market Cap

450

Higher than Peers by 308

Current Share price multiplied by latest total number of shares outstanding

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Arcturus Therapeutics Holdings (ARCT)	450	--	--	--	--	--
Peer Median	142	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly